SCHWITZ BIOTECH
Biosimilars Products

Biosimilars Products

Send Inquiry

Biosimilars Products

Sr. No.

Name of Product

Strength

USE

1

Filgrastim Prefilled Syringe

300 mcg/ml

Neutropenia (Oncology)

300 mcg/0.5 ml

480 mcg/0.5 ml

150 mcg/ml

150 mcg/0.5 ml

300 mcg/ml  Vial

480mcg/0.8 ml

 

2

Pegylated rHu Erythropoietin Injection

50mcg/0.3ml

Treatment of Anemia with CHF

75mcg/0.3ml

100mcg/0.3ml

 

 

3

Teriparatide [rHu PTH (1-34)] Injection for

Subcutaneous use only (r-DNA origin)

750 mcg / 3ml CRG

Postmenopausal women with Osteoporosis

 

 

 

 

4

Rituximab Conc. Sol. Infusion (Injection)

100 mg /10 ml   &  500 mg / 50 ml

Non-Hodgkin's Lymphoma (NHL) - Oncology

 

5

Recombinant Follitropin ALFA (rHu FSH Injection)

300 IU/0.48ml CRG

Anovulation in women

450 IU/0.72ml CRG

900 IU/1.44ml CRG

75 IU/0.12ml PFS

150 IU/0.24ml PFS

600 IU/0.96ml CRG

1200IU/1.92ml Vial

225IU/0.36ml PFS

300IU/0.48ml PFS

 

6

Erythropoietin ALFA Injection (PFS)

Erythropoietin Inj. (2000IU/ml)

Anemia in CHF & in Cancer Patients, HIV patients & in blood transfusion

Erythropoietin Inj. (4000IU/ml)

Erythropoietin Inj. (10,000IU/ml)

Erythropoietin Inj. (3000IU/0.3ml)

Erythropoietin Inj. (6000 IU/0.6ml)

Erythropoietin Inj. (4000 IU/0.4ml)

rHu EPO Alfa Injection 2000 IU/0.5ml

Erythropoietin Inj. (5000IU/0.5ml)

rHu EPO Alfa Injection 10000 IU/ml Vial

rHu EPO Alfa Injection 40000 IU/ml

Erythropoietin Inj. (2000IU/ml) Vial

Erythropoietin Inj. (4000IU/ml) Vial

Erythropoietin Inj. 10,000IU/ml Vial

rHu EPO Alfa Injection 20000IU/2ml Vial

 

7

Pegfilgrastim Injection Vial / PFS

6 mg / 0.6 ml & 6 mg / ml

In Treatment of Neutropenia

 

8

Etanercept Solution for Injection

0.25 mg / 0.5 ml & 50 mg / 1 ml

Rheumatoid Arthritis

 

9

Pegylated Recombinant Human Interferon Alfa 2b

80 mcg/0.5 ml

In Hepatitis B and Hepatitis C

50 mcg/0.5 ml

150 mcg/0.5 ml

100 mcg/0.5 ml

120 mcg/0.5 ml

 

 

10

Interferon Alfa 2b in PFS

3 MIU / 1 ml & 5 MIU / 1 ml

For the treatment of Alpha 2b chronic hepatitis B, C &

chronic myeloid leukemia patient

 

 

11

Ranibizumab Injection

10 mg / ml vial

Neovascular (wet) age related macular degeneration (AMD)